The abstract is read at the publisher; the summary is JClub's.
Across 49 of 124 (40%) healthcare institutions worldwide, clinical pharmacogenomics programs reported a median of 9 personnel (IQR 7–19; range 2–125) supporting implementation.
- Why it matters: The field lacks a clear, global picture of what staffing, infrastructure, and funding are actually used to run pharmacogenomics programs, limiting planning and benchmarking.
- What they did: An international survey by the Pharmacogenomics Global Research Network Implementation Working Group collected site and program data from institutions planning or implementing PGx, including team composition and funding.
- The result: Post-launch programs (n=43) used multidisciplinary teams with heterogeneous staffing models, but most included a PGx pharmacist, physician, laboratory scientist, and informaticist, with pharmacists present in 86% (37 of 43) and compensated in 84% (31 of 37).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.